Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USDA database

This article was originally published in The Tan Sheet

Executive Summary

The Department of Agriculture releases measures of antioxidant capacities for 277 selected foods on Nov. 6. The new database provides "easy access to antioxidant values for a wide variety of foods, many of which may be excellent sources of healthful compounds," USDA says. In September, industry group executives said the database being developed by the Department of Agriculture to track consumers' dietary supplement intake could "help firms with information they need for product development," (1"The Tan Sheet" Sept. 3, 2007, p. 17). "The database will be used by scientists to help guide ongoing research into how antioxidants may correlate to health benefits," USDA says...

You may also be interested in...



USDA Supplement Ingredient Database Greeted As Effective Tool For Firms

Industry group executives say a database the Department of Agriculture is developing to track consumers' dietary supplement intake could help firms with information they need for product development

Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

 

 

Pipeline Watch: Phase III Readouts For Surufatinib, Tislelizumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Topics

UsernamePublicRestriction

Register

PS101097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel